Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring

被引:7
|
作者
Perez-Palomar, Blanca [1 ,2 ,3 ,4 ,5 ]
Erdozain, Amaia M. [1 ,2 ]
Erkizia-Santamaria, Ines [1 ]
Ortega, Jorge E. [1 ,2 ,3 ]
Meana, J. Javier [1 ,2 ,3 ]
机构
[1] Univ Basque Country UPV EHU, Dept Pharmacol, Leioa 48940, Bizkaia, Spain
[2] ISCIII, Ctr Invest Biomed Red Salud Mental CIBERSAM, Leioa, Spain
[3] Biocruces Bizkaia Hlth Res Inst, Bizkaia, Spain
[4] Washington Univ St Louis, Dept Anesthesiol, St Louis, MO 63110 USA
[5] Univ Hlth Sci & Pharm St Louis, Dept Pharmaceut & Adm Sci, St Louis, MO 63110 USA
关键词
Maternal Immune Activation; Microdialysis; Dopamine; Noradrenaline; D-1; Receptors; D-2; Cognitive Impairment; POLYINOSINIC-POLYCYTIDYLIC ACID; NMDA-RECEPTOR ANTAGONISTS; GLUTAMATE; RECEPTORS; WORKING-MEMORY; PREFRONTAL CORTEX; DOPAMINE RELEASE; NEURODEVELOPMENTAL MODEL; PREPULSE INHIBITION; PRENATAL INFECTION; SICKNESS BEHAVIOR;
D O I
10.1007/s11481-023-10070-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BackgroundImpairment of specific cognitive domains in schizophrenia has been associated with prefrontal cortex (PFC) catecholaminergic deficits. Among other factors, prenatal exposure to infections represents an environmental risk factor for schizophrenia development in adulthood. However, it remains largely unknown whether the prenatal infection-induced changes in the brain may be associated with concrete switches in a particular neurochemical circuit, and therefore, if they could alter behavioral functions.MethodsIn vitro and in vivo neurochemical evaluation of the PFC catecholaminergic systems was performed in offspring from mice undergoing maternal immune activation (MIA). The cognitive status was also evaluated. Prenatal viral infection was mimicked by polyriboinosinic-polyribocytidylic acid (poly(I:C)) administration to pregnant dams (7.5 mg/kg i.p., gestational day 9.5) and consequences were evaluated in adult offspring.ResultsMIA-treated offspring showed disrupted recognition memory in the novel object recognition task (t = 2.30, p = 0.031). This poly(I:C)-based group displayed decreased extracellular dopamine (DA) concentrations compared to controls (t = 3.17, p = 0.0068). Potassium-evoked release of DA and noradrenaline (NA) were impaired in the poly(I:C) group (DA: F-t[10,90] = 43.33, p < 0.0001; F-tr[1,90] = 1.224, p = 0.2972; F-i[10,90] = 5.916, p < 0.0001; n = 11); (NA: F-t[10,90] = 36.27, p < 0.0001; F-tr[1,90] = 1.841, p = 0.208; F-i[10,90] = 8.686, p < 0.0001; n = 11). In the same way, amphetamine-evoked release of DA and NA were also impaired in the poly(I:C) group (DA: F-t[8,328] = 22.01, p < 0.0001; F-tr[1,328] = 4.507, p = 0.040; F-i[8,328] = 2.319, p = 0.020; n = 43); (NA: F-t[8,328] = 52.07; p < 0.0001; F-tr[1,328] = 4.322; p = 0.044; F-i[8,398] = 5.727; p < 0.0001; n = 43). This catecholamine imbalance was accompanied by increased dopamine D-1 and D-2 receptor expression (t = 2.64, p = 0.011 and t = 3.55, p = 0.0009; respectively), whereas tyrosine hydroxylase, DA and NA tissue content, DA and NA transporter (DAT/NET) expression and function were unaltered.ConclusionsMIA induces in offspring a presynaptic catecholaminergic hypofunction in PFC with cognitive impairment. This poly(I:C)-based model reproduces catecholamine phenotypes reported in schizophrenia and represents an opportunity for the study of cognitive impairment associated to this disorder.
引用
收藏
页码:348 / 365
页数:18
相关论文
共 50 条
  • [31] EFFECTS OF MATERNAL IMMUNE ACTIVATION ON OFFSPRING PREFRONTAL GABAERGIC CIRCUITRY AND ANXIETY
    Canetta, Sarah Elizabeth
    Brown, Alan
    Kellendonk, Christoph
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S1 - S2
  • [32] Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring
    Zuckerman, L
    Weiner, I
    JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (03) : 311 - 323
  • [33] Effects of maternal immune activation on dopamine activity in male and female offspring
    De Felice, M.
    Aroni, S.
    Muntoni, A. L.
    Frau, R.
    Fanni, S.
    Pardu, A.
    Devoto, P.
    Pistis, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S93 - S94
  • [34] Maternal immune activation alters brain microRNA expression in mouse offspring
    Sunwoo, Jun-Sang
    Jeon, Daejong
    Lee, Soon-Tae
    Moon, Jangsup
    Yu, Jung-Suk
    Park, Dong-Kyu
    Bae, Ji-Yeon
    Lee, Doo Young
    Kim, Sangwoo
    Jung, Keun-Hwa
    Park, Kyung-Il
    Jung, Ki-Young
    Kim, Manho
    Lee, Sang Kun
    Chu, Kon
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (10): : 1264 - 1276
  • [35] Maternal immune activation increases seizure susceptibility in juvenile rat offspring
    Yin, Ping
    Zhang, Xin-Ting
    Li, Jun
    Yu, Lin
    Wang, Ji-Wen
    Lei, Ge-Fei
    Sun, Ruo-Peng
    Li, Bao-Min
    EPILEPSY & BEHAVIOR, 2015, 47 : 93 - 97
  • [36] Maternal Immune Activation Alters Mitochondrial Membrane Potential in Offspring in Vivo
    Donegan, Jennifer
    Bazhin, Arkadiy
    Solodnikova, Ekaterina
    Goun, Elena
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S268 - S268
  • [37] Association of Maternal Immune Activation during Pregnancy and Neurologic Outcomes in Offspring
    Jain, Samhita
    Baer, Rebecca J.
    McCulloch, Charles E.
    Rogers, Elizabeth
    Rand, Larry
    Jelliffe-Pawlowski, Laura
    Piao, Xianhua H.
    JOURNAL OF PEDIATRICS, 2021, 238 : 87 - +
  • [38] Maternal Immune Activation and Related Factors in the Risk of Offspring Psychiatric Disorders
    Conway, Fiona
    Brown, Alan S.
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [39] Maternal immune activation increases neuroinflammation and aggravates EAE in adult offspring
    Zager, Adriano
    Peron, Jean-Pierre S.
    Campos-Rodrigues, Sandra
    Palermo-Neto, Joao
    FASEB JOURNAL, 2013, 27
  • [40] Mouse maternal odontogenic infection with Porphyromonas gingivalis induces cognitive decline in offspring
    Ishida, Eri
    Furusho, Hisako
    Renn, Ting-Yi
    Shiba, Fumie
    Chang, Hung-Ming
    Oue, Hiroshi
    Terayama, Ryuji
    Ago, Yukio
    Tsuga, Kazuhiro
    Miyauchi, Mutsumi
    FRONTIERS IN PEDIATRICS, 2023, 11